Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

REVOLUTIONARY THERAPY OF APHASIA

Project description

A device to cure aphasia

Aphasia is a disorder resulting from damage to specific brain regions. It affects language production and linguistic communication without affecting intelligence. Each year, about 300 000 cases occur in Europe alone as a result of strokes, and an effective cure depends on timely diagnosis and treatment, which could take place at home. Unfortunately, due to limited access to immediate therapy, less than half of all patients fully recover. The EU-funded VOIC project will radically change that by bringing to the market the first dedicated device for aphasia therapy. The VOIC technology is a system enabling comprehensive rehabilitation based on non-invasive brain stimulation technology in a patient-centred approach, adapted to work in rehabilitation clinics and patient homes.

Objective

Home therapy is the future of many available medical therapies. Home therapy does not require any additional medical staff support or hospital space, resulting in large savings for healthcare services. Aphasia therapy is one which could be potentially moved to the home setting, resulting in great benefits for patients. Aphasia is a kind of brain damage caused mainly by a stroke which prevents a person’s linguistic communication while maintaining the intellect intact. It is independent of age or sex, hence everyone is at risk - every year in EU there are almost 300 000 new cases.
Most important for aphasia therapy is to start directly after it is diagnosed. Neuro Device Group with project VOIC aims at providing easy to use neuro-stimulation medical device coupled with software to provide the therapy at home setting. Currently, there is no dedicated device for aphasia therapy on the market, hence VOIC is a market-creating innovation. Our proposed therapy is more efficient and costs much less than the state-of-the-art standard speech therapy with a neuro-therapist. VOIC will be offered to patients such that the therapy starts quickly at a lower cost of a few thousand euros. We also want to offer VOIC to the therapists who can attend more patients at the same time, providing an additional source of income and patient satisfaction. The indirect benefit of the healthcare and retirement systems cannot be underestimated: lower cost of therapy and reduced cost of social benefits per patient, which can sum up to €3bn savings every year.
The project will be well aligned with the company strategy and global trends in medical treatment. The market for medical devices is rapidly growing at 14% CAGR and is going to reach €13bn in 2023. The market demand has been initially confirmed with patients, medical universities, and big medical devices distributors.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

SME-1 - SME instrument phase 1

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

NEURO DEVICE GROUP SPOLKA AKCYJNA
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 50 000,00
Address
UL. PLOWIECKA 1 LOK.
04-501 WARSZAWA
Poland

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Makroregion województwo mazowieckie Warszawski stołeczny Miasto Warszawa
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 71 429,00
My booklet 0 0